Danshen (Salvia miltiorrhiza) extract inhibits proliferation of breast cancer cells via modulation of akt activity and p27 level

Phytotherapy Research

Volumn 24, Issue 2, 2010, Pages 198-204

  Yang, Wonseok ^a   Ju, Ji Hyun ^a   Jeon, Min Jeong ^a   Han, Xiangzi ^a,b   Shin, Incheol ^a  

^a Hanyang University   (South Korea)

^b YANBIAN UNIVERSITY   (China)

Author keywords

Breast cancer; Danshen (Salvia miltiorrhiza); HER2; TCM (traditional Chinese medicine)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN KINASE B; PROTEIN P27; SALVIA MILTIORRHIZA EXTRACT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SALVIA MILTIORRHIZA; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; PHENANTHROLINES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; SALVIA MILTIORRHIZA;

SALVIA MILTIORRHIZA;

EID: 75849119583     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2945     Document Type: Article

References (28)

1. Alessi DR, Andjelkovic M, Caudwell B et al. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551.
2. Auld CA, Morrison RF. 2006. Evidence for cytosolic p27(Kip1) ubiquitylation and degradation during adipocyte hyperplasia. Obesity (Silver Spring) 14: 2136-2144.
3. Blauer M, Heinonen PK, Rovio P, Ylikomi T. 2008. Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model. Eur J Pharmacol 592: 13-18.
4. Bonovas S, Tsantes A, Drosos T, Sitaras NM. 2008. Cancer chemoprevention: a summary of the current evidence. Anticancer Res 28: 1857-1866.
5. Brody JG, Rudel RA. 2003. Environmental pollutants and breast cancer. Environ Health Perspect 111: 1007-1019.
6. Cheng TO. 2007. Cardiovascular effects of Danshen. Int J Cardiol 121: 9-22.
7. Cyranoski D. 2001. Hong Kong seeks secrets of Chinese medicine. Nature 412: 7.
8. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. 1997. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16: 1647-1655.
9. Kim JB, Lee KM, Ko E et al. 2008. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Planta Med 74: 39-42.
10. Larrea MD, Liang J, Da Silva T et al. 2008. Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4. Mol Cell Biol 28: 6462-6472.
11. Liang J, Zubovitz J, Petrocelli T et al. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8: 1153-1160.
12. Mitra AK, Faruque FS. 2004. Breast cancer incidence and exposure to environmental chemicals in 82 counties in Mississippi. South Med J 97: 259-263.
13. Niu XL, Ichimori K, Yang X et al. 2000. Tanshinone II-A inhibits low density lipoprotein oxidation in vitro. Free Radic Res 33: 305-312.
14. Olayioye MA. 2001. Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members. Breast Cancer Res 3: 385-389.
15. Schwartsmann G, Brondani da Rocha A, Berlinck RG, Jimeno J. 2001. Marine organisms as a source of new anticancer agents. Lancet Oncol 2: 221-225.
16. Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
17. Shin I, Arteaga CL. 2006. Expression of active Akt protects against tamoxifen-induced apoptosis in MCF-7 Cells. IUBMB Life 58: 664-669.
18. Shin I, Rotty J, Wu FY, Arteaga CL. 2005. Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry. J Biol Chem 280: 6055-6063.
19. Shin I, Yakes FM, Rojo F et al. 2002. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8: 1145-1152.
20. Tomoda K, Kubota Y, Kato J. 1999. Degradation of the cyclindependent- kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398: 160-165.
21. Viglietto G, Motti ML, Bruni P et al. 2002. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8: 1136-1144.
22. Vogel VG. 2007. Chemoprevention strategies 2006. Curr Treat Options Oncol 8: 74-88.
23. Wang AM, Sha SH, Lesniak W, Schacht J. 2003. Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 47: 1836-1841.
24. Wang X, Wei Y, Yuan S et al. 2005. Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 116: 799-807.
25. Xian M, Ito K, Nakazato T et al. 2007. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway. Cancer Sci 98: 118-126.
26. Yakes FM, Chinratanalab W, Ritter CA, King W, Seelig S, Arteaga CL. 2002. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action. Cancer Res 62: 4132-4141.
27. Yarden Y, Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137.
28. Zhou L, Chan WK, Xu N et al. 2008. Tanshinone IIA, an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest. Life Sci 83: 394-403.